Role of Osterix+ Osteolineage Cells in Primary and Metastatic Breast Cancer
Osterix 骨细胞在原发性和转移性乳腺癌中的作用
基本信息
- 批准号:10585653
- 负责人:
- 金额:$ 40.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-20 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:4T1Adoptive TransferAdultAffectAntigen PresentationBiological AssayBone MarrowBone Marrow TransplantationBreast CarcinomaCell SeparationCellsChIP-seqCirculationComplementDepositionDevelopmentDiseaseDistantEctopic ExpressionEmbryoEnvironmentExtracellular MatrixFibroblastsGenerationsGenesGeneticGrowthGrowth FactorHeterogeneityImmuneInfiltrationInjectionsInterruptionInvestigationLungMalignant NeoplasmsMammary NeoplasmsMesenchymalMetastatic breast cancerMusNeoplasm MetastasisNormal CellOsteoblastsPatientsPopulationProductionPrognosisReporter GenesRoleSiteSkeletonSoilSourceSpecificityStromal CellsSurfaceTransplantationTumor Markersbonebreast cancer progressioncancer cellcancer therapycytokinedesignfightingimmunoregulationmalignant breast neoplasmmammarymature animalmesenchymal stromal cellmouse modelneoplastic cellnovelnovel markernovel therapeutic interventionosteogenicpolyoma middle tumor antigenpostnatalpremalignantprogenitorpromoterrecruitresponsesingle-cell RNA sequencingskeletalskeletal stem celltranscription factortumortumor growthtumor microenvironmenttumor progressiontumorigenic
项目摘要
ABSTRACT
In order to survive, grow and metastasize, tumors need the support of a favorable host environment. Local
changes in normal cells in close proximity to a developing tumor can create a favorable tumor micro-environment
(TME) that is necessary for tumor growth. Mesenchymal populations, including cancer-associated fibroblasts
(CAFs), secrete pro- tumorigenic and immune suppressive factors, and produce extracellular matrix to create a
stiffer, tumor-conducive soil. Several CAF subsets with specific functions have been identified, however, whether
distinct CAF subsets derive from the same progenitor that acquire functional specificity during tumor progression
or from different progenitors committed to give rise to a specific CAF population, is under investigation.
We recently made the unexpected observation that cells expressing bone osteolineage marker Osterix (Osx) are
present in the TME of tumors outside the bone and support tumor growth. In adult animals, Osx is expressed by
committed osteoblasts (OB) and drives their differentiation. Surprisingly, we detected Osx in stromal cells,
isolated from various breast cancer tumors, expressing CAF and OB makers, and in the tumor-associated stroma
of patients with breast carcinomas. Co-injection of Osx+ cells with tumor cells enhance tumor growth.
Importantly, Osx expression correlates with poor prognosis in breast cancer. Based on these rather unexpected
findings, we hypothesize that bone-derived osteolineage Osx+ cells represent a novel subset of tumor infiltrating
stromal populations contributing to tumor progression and CAF diversity. Aim 1 will determine the functional
relevance of Osx+ cells in the TME and pre-metastatic sites; Aim 2 will determine the origin of Osx+ cells in the
TME and pre-metastatic sites. This information will broaden the concept of cellular heterogeneity within the TME
and offer a new platform for targeting the stroma with the purpose of inhibiting tumor growth.
抽象的
为了生存,生长和转移,肿瘤需要有利的宿主环境的支持。当地的
正常细胞与发育中的肿瘤紧邻的变化会产生有利的肿瘤微环境
(TME)是肿瘤生长所必需的。间充质种群,包括癌症相关的成纤维细胞
(CAFS),分泌肿瘤和免疫抑制因素,并产生细胞外基质以创建一个
僵硬,肿瘤有用的土壤。但是,已经确定了几个具有特定功能的CAF子集
独特的CAF子集源自在肿瘤进展过程中获得功能特异性的同一祖细胞
或来自承诺引起特定CAF人群的不同祖细胞正在研究。
我们最近对表达骨骼骨丁质标记的细胞Osterix(OSX)进行了意外观察
存在于骨外肿瘤的TME中并支持肿瘤生长。在成年动物中,OSX由
犯有成骨细胞(OB)并驱动其分化。令人惊讶的是,我们在基质细胞中检测到OSX,
从各种乳腺癌肿瘤中分离出来,表达CAF和OB制造商,以及在肿瘤相关的基质中
患有乳腺癌的患者。 OSX+细胞与肿瘤细胞共同注射可增强肿瘤的生长。
重要的是,OSX表达与乳腺癌的预后不良相关。基于这些相当出乎意料的
调查结果,我们假设骨衍生的骨丁质OSX+细胞代表了肿瘤浸润的新型子集
基质种群有助于肿瘤进展和CAF多样性。 AIM 1将决定功能
OSX+细胞在TME和中转移部位的相关性; AIM 2将确定OSX+细胞在
TME和前移位部位。此信息将扩大TME中细胞异质性的概念
并提供一个针对基质的新平台,目的是抑制肿瘤生长。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roberta Faccio其他文献
Roberta Faccio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roberta Faccio', 18)}}的其他基金
Role of Bone in Primary and Metastatic Cancer
骨在原发性和转移性癌症中的作用
- 批准号:
10671085 - 财政年份:2020
- 资助金额:
$ 40.99万 - 项目类别:
Role of Bone in Primary and Metastatic Cancer
骨在原发性和转移性癌症中的作用
- 批准号:
10442364 - 财政年份:2020
- 资助金额:
$ 40.99万 - 项目类别:
Role of Bone in Primary and Metastatic Cancer
骨在原发性和转移性癌症中的作用
- 批准号:
9887365 - 财政年份:2020
- 资助金额:
$ 40.99万 - 项目类别:
Novel Regulators of Inflammatory Arthritis and Bone Erosion
炎症性关节炎和骨侵蚀的新型调节剂
- 批准号:
9893817 - 财政年份:2015
- 资助金额:
$ 40.99万 - 项目类别:
REGULATORY PATHWAYS IN OSTEOCLAST FORMATION AND FUNCTION
破骨细胞形成和功能的调节途径
- 批准号:
7810845 - 财政年份:2009
- 资助金额:
$ 40.99万 - 项目类别:
Regulatory Pathways in Osteoclasts and Immune Cells during Inflammatory Arthritis
炎症性关节炎期间破骨细胞和免疫细胞的调节途径
- 批准号:
8144338 - 财政年份:2006
- 资助金额:
$ 40.99万 - 项目类别:
Regulatory Pathways in Osteoclasts and Immune Cells during Inflammatory Arthritis
炎症性关节炎期间破骨细胞和免疫细胞的调节途径
- 批准号:
8719733 - 财政年份:2006
- 资助金额:
$ 40.99万 - 项目类别:
Regulatory Pathways in Osteoclast Formation and Function
破骨细胞形成和功能的调节途径
- 批准号:
7672245 - 财政年份:2006
- 资助金额:
$ 40.99万 - 项目类别:
REGULATORY PATHWAYS IN OSTEOCLAST FORMATION AND FUNCTION
破骨细胞形成和功能的调节途径
- 批准号:
7289766 - 财政年份:2006
- 资助金额:
$ 40.99万 - 项目类别:
Regulatory Pathways in Osteoclast Formation and Function
破骨细胞形成和功能的调节途径
- 批准号:
7483101 - 财政年份:2006
- 资助金额:
$ 40.99万 - 项目类别:
相似海外基金
Regulation of prostate organogenesis by tissue-resident macrophages
组织驻留巨噬细胞对前列腺器官发生的调节
- 批准号:
10555589 - 财政年份:2023
- 资助金额:
$ 40.99万 - 项目类别:
Modulating the PD-1/PD-L1 checkpoint to promote antitumor activity of HER2 CAR T cells in patients with sarcoma
调节PD-1/PD-L1检查点促进肉瘤患者HER2 CAR T细胞的抗肿瘤活性
- 批准号:
10562836 - 财政年份:2023
- 资助金额:
$ 40.99万 - 项目类别:
“Pharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment response”
– NR4A1 和 NR4A2 的药理学靶向激活胶质母细胞瘤治疗反应 –
- 批准号:
10744524 - 财政年份:2023
- 资助金额:
$ 40.99万 - 项目类别:
Elucidating the role of type I interferon signaling and macrophage-derived inflammation in the juvenile host with viral pneumonia
阐明 I 型干扰素信号传导和巨噬细胞衍生炎症在病毒性肺炎幼年宿主中的作用
- 批准号:
10651426 - 财政年份:2023
- 资助金额:
$ 40.99万 - 项目类别: